BioSpace News Archive

Deals

Madrigal Pharmaceuticals Prices Public Offering of Common Stock

Madrigal Pharmaceuticals, Inc. announced the pricing of an underwritten registered public offering of 1,347,232 shares of its common stock at a public offering price of $305.00 per share.

July 5, 2018
·
4 min read
Business

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer

Arbutus Biopharma Corporation announced the appointment of David Hastings as Chief Financial Officer, effective June 11, 2018.

July 5, 2018
·
4 min read
BioCapital

Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization

Insulin-Dependent Patients Will Be Enrolled in Clinical Trial Using iSage’s FDA Cleared Insulin Titration Application

July 5, 2018
·
3 min read
Business

Amarantus Provides Update on Elto Pharma Capital Formation Plan

Amarantus Bioscience Holdings, Inc. provided an update to the marketplace on its capital formation plans for its wholly-owned subsidiary Elto Pharma, Inc.

July 5, 2018
·
4 min read
Business

The American Health Council Selects Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to Industry Board

The American Health Council selected Ruth Dapaah-Afriyie, Pharm.D., B.Pharm., BCACP, CDOE, CVDOE to its Industry Board.

July 5, 2018
·
5 min read
Drug Development

International Stem Cell Corporation Doses First Patient of the Third Cohort in Parkinson’s Disease Clinical Trial

International Stem Cell Corporation announced that the first patient of the third cohort of the clinical trial for Parkinson’s disease was successfully transplanted with 70,000,000 ISC-hpNSC®.

July 5, 2018
·
7 min read
Business

Daxor Corporation Appoints Kathryn A. Kornafel Vice President of Marketing and Commercial Development

Daxor Corporation announces the appointment of Kathryn A. Kornafel as vice president of Marketing and Commercial Development.

July 5, 2018
·
3 min read
FDA

Wright Medical Group N.V. Announces FDA Premarket Approval for AUGMENT® Injectable Bone Graft

Clinically Proven, Cost-Effective, Injectable Formulation of AUGMENT® Approved in U.S. for Ankle and/or Hindfoot Fusion

July 5, 2018
·
6 min read
Drug Development

New England Journal of Medicine Publishes Novavax’ NanoFlu Clinical Trial Data

NanoFlu Phase 1/2 trial data published in a peer-reviewed letter to the editor in The New England Journal of Medicine

July 5, 2018
·
4 min read
Business

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2018 and Provides Conference Call InformationConference Call Scheduled for Friday, June 15 at 1:00 PM EDT

Elite Pharmaceuticals, Inc. announced results for the fiscal year ended March 31, 2018

July 5, 2018
·
4 min read